Insmed Incorporated (INSM)
NASDAQ: INSM · IEX Real-Time Price · USD
25.10
+0.17 (0.68%)
May 16, 2024, 4:00 PM EDT - Market closed
Insmed Revenue
Insmed had revenue of $315.49M in the twelve months ending March 31, 2024, with 22.54% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $75.50M with 15.77% year-over-year growth. In the year 2023, Insmed had annual revenue of $305.21M with 24.39% growth.
Revenue (ttm)
$315.49M
Revenue Growth
+22.54%
P/S Ratio
11.79
Revenue / Employee
$345,936
Employees
912
Market Cap
3.72B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 305.21M | 59.85M | 24.39% |
Dec 31, 2022 | 245.36M | 56.90M | 30.19% |
Dec 31, 2021 | 188.46M | 24.05M | 14.63% |
Dec 31, 2020 | 164.41M | 27.95M | 20.48% |
Dec 31, 2019 | 136.47M | 126.63M | 1,287.56% |
Dec 31, 2018 | 9.84M | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 11.50M | - | - |
Dec 31, 2012 | 0 | - | - |
Dec 31, 2011 | 4.42M | -2.50M | -36.18% |
Dec 31, 2010 | 6.92M | -3.45M | -33.28% |
Dec 31, 2009 | 10.37M | -1.33M | -11.33% |
Dec 31, 2008 | 11.70M | 4.12M | 54.32% |
Dec 31, 2007 | 7.58M | 6.56M | 639.61% |
Dec 31, 2006 | 1.03M | 894.00K | 682.44% |
Dec 31, 2005 | 131.00K | -6.00K | -4.38% |
Dec 31, 2004 | 137.00K | -13.00K | -8.67% |
Dec 31, 2003 | 150.00K | -1.81M | -92.33% |
Dec 31, 2002 | 1.96M | 1.66M | 560.47% |
Dec 31, 2001 | 296.00K | 236.00K | 393.33% |
Dec 31, 2000 | 60.00K | - | - |
Dec 31, 1999 | 0 | - | - |
Dec 31, 1998 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Perrigo Company | 4.56B |
Alkermes | 1.73B |
RadNet | 1.66B |
Integer Holdings | 1.63B |
HUTCHMED (China) | 838.00M |
Ultragenyx Pharmaceutical | 442.59M |
Axsome Therapeutics | 251.02M |
PROCEPT BioRobotics | 156.33M |
INSM News
- 7 days ago - Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update - PRNewsWire
- 9 days ago - Insmed To Present at the BofA Securities Health Care Conference 2024 - PRNewsWire
- 13 days ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 21 days ago - Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 - PRNewsWire
- 7 weeks ago - Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference - PRNewsWire
- 2 months ago - Insmed To Present at Three March Conferences - PRNewsWire
- 2 months ago - Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health - PRNewsWire
- 3 months ago - Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update - PRNewsWire